TITLE

Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity

AUTHOR(S)
Xiao Meng; Liangyi Qie; Yuanyuan Wang; Ming Zhong; Li Li
PUB. DATE
December 2009
SOURCE
Clinical & Investigative Medicine;Dec2009, Vol. 32 Issue 6, pE238
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Several studies have shown arterial stiffness changes associated with coronary artery disease (CAD). Recently, statins were reported to improve arterial stiffness. The aim of the study was to evaluate the effect of atorvastatin on arterial stiffness in CAD patients using pulse wave velocity (PWV). Methods: We evaluated 63 patients with hyperlipemia and CAD. Forty-three patients were given 10mg atorvastatin daily and 20 patients were assigned to a low-fat diet. Carotid-femoral PWV (PWV-CF), carotid-radial PWV (PWV-CR) and carotid-distal PWV (PWV-CD) were measured in all patients. Results: Compared with baseline, PWV-CF, PWV-CR and PWV-CD decreased after therapy in the atorvastatin group (13.22±3.39 & 11.85±2.87; 11.85±2.72 & 10.73±2.31; and 11.04±1.99 & 10.15±1.75, P<0.05). There was no difference in the control group (13.29±2.89 & 13.93±2.89; 11.52±2.25 & 12.31±2.22; and 10.46±1.86 & 11.15±1.85, P>0.05). After treatment, values of total cholesterol, triglyceride and low density lipoprotein (LDL) cholesterol were reduced in the 2 groups (P<0.05). Conclusions: The study demonstrated that atorvastatin can improve arterial stiffness in CAD patients independent of its lipid-lowering properties.
ACCESSION #
47781870

 

Related Articles

  • Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data. Bell, Katy J.; Kirby, Adrienne; Hayen, Andrew; Irwig, Les; Glasziou, Paul // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/29/2011, Vol. 342 Issue 7791, p269 

    The article discusses research on the accuracy of cholesterol monitoring in detecting non-adherence with cholesterol lowering treatment. It notes that adherence after starting lipid lowering treatment varies between patients. The effects of pravastatin with placebo were compared in patients with...

  • Vascular viewpoint. Anand, Sonia S. // Vascular Medicine;2003, Vol. 8 Issue 4, p289 

    Shares views on the effect of statins on low density lipoprotein, cholesterol, ischaemic heart disease, and stroke. Determination whether how much statins can reduce serum concentrations of low density lipoprotein cholesterol according to drug, dose, and duration of treatment; Number of patients...

  • STATINS, STRESS, CORONARY DISEASE AND HYPERTENSION.  // Health & Stress;2003, Issue 9, p1 

    Reports on developments in statins. Guidelines for prescribing statins; Discovery of a class of statin medications that reduced low density lipoproteins (LDL), heart attack and death rates; Relationship of LDL to individual and population risk of coronary heart disease.

  • Atorvastatin More Effective in Reducing LDL Cholesterol. Sadovsky, Richard // American Family Physician;7/15/2002, Vol. 66 Issue 2, p325 

    Presents two abstracts of studies. 'Comparison of Efficacy and Safety of Atorvastatin and Simvastatin in Patients With Dyslipidemia With and Without Coronary Heart Disease,' by D.G. Karalis et al., from the March 15, 2002 issue of the 'American Journal of Cardiology'; 'Achieving and Maintaining...

  • Phytosterols and Policosanol as Adjunctive or Alternative Therapies to Statin Drugs. Acocella, Steven // Nutritional Perspectives: Journal of the Council on Nutrition;Jan2006, Vol. 29 Issue 1, p40 

    PHYTOSTEROLS AND POLICOSANOL HAVE BEEN SHOWN TO REDUCE SERUM LEVELS OF LDL AND TOTAL CHOLESTEROL. The development of esterification of phytosterols allowing them to be incorporated into easily consumed foods such as enriched margarines and the development of functional foods has led to a renewed...

  • Heartsick America. Cowley, Geoffrey // Newsweek (Atlantic Edition);05/28/2001 (Atlantic Edition), Vol. 137 Issue 22, p63 

    Discusses the findings of a federal report on the benefits of cholesterol reduction. Recommendation of drug use to reduce high cholesterol levels; Reduction of risk for coronary heart disease; Different limits which were recommended on low-density lipoproteins (LDL) cholesterol.

  • Heartsick America. Cowley, Geoffrey // Newsweek (Pacific Edition);05/28/2001 (Pacific Edition), Vol. 137 Issue 22, p63 

    Discusses the findings of a federal report on the benefits of cholesterol reduction. Recommendation of drug use to reduce high cholesterol levels; Reduction of risk for coronary heart disease; Different limits which were recommended on low-density lipoproteins (LDL) cholesterol.

  • Heartsick America. Cowley, Geoffrey // Newsweek;5/28/2001, Vol. 137 Issue 22, p43 

    Discusses the findings of a federal report which state benefits of cholesterol reduction. Recommendation of drug use to reduce high cholesterol levels; Reduction of risk for coronary heart disease; Different limits which were recommended on low-density lipoproteins (LDL) cholesterol.

  • Optimal Medical Management of Peripheral Arterial Disease. Rice, Terry W.; Lumsden, Alan B. // Vascular & Endovascular Surgery;Aug/Sep2006, Vol. 40 Issue 4, p312 

    Patients with peripheral vascular disease are less likely to receive optimal medical management than patients with coronary artery disease. However, early medical treatment is critical because it is profoundly beneficial and the benefits are maximized. Even in patients with advanced disease...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics